Eli Lilly (LLY) Inventory (2009 - 2026)

Eli Lilly has reported Inventory for 18 years, with the latest figure at $14.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 56.04% year-over-year to $14.5 billion; the trailing twelve-month figure through Mar 2026 stood at $14.5 billion (up 56.04% YoY), and the FY2025 full-year result was $13.7 billion, up 81.1% from the prior year.
• Inventory for Q1 2026 stood at $14.5 billion, up from $13.7 billion in the prior quarter.
• The five-year high for Inventory was $14.5 billion in Q1 2026, with the low at $3.8 billion in Q3 2022.
• Historically, Inventory has averaged $7.3 billion across 5 years, with a median of $6.1 billion in 2024.
• Annual changes were most pronounced in 2022 — Inventory fell 1.95% — and 2025, when it soared 81.1%.
• Eli Lilly's Inventory stood at $4.3 billion in 2022, then soared by 33.95% to $5.8 billion in 2023, then soared by 31.46% to $7.6 billion in 2024, then soared by 81.1% to $13.7 billion in 2025, then advanced by 5.71% to $14.5 billion in 2026.
• The last three Inventory figures came in at $14.5 billion (Q1 2026), $13.7 billion (Q4 2025), and $12.2 billion (Q3 2025), per Business Quant data.